SurgicEye GmbH provides solutions and services beyond molecular imaging. SurgicEye is providing innovative solutions to expand the use of nuclear medicine images from pure diagnosis to interventions for radionuclid therapy and radio-guided surgery. With the declipse®SPECT , SurgicEye enables increased quality through application specific imaging. SurgicEye is also well known as a reliable partner in the development of dose planing and monitoring solutions, dosimetry in radionuclid therapy, hybrid nuclear imaging, ultrasound / SPECT image fusion, interventional nuclear medicine and needle guidance, and intraoperative SPECT imaging as well as guidance systems for surgery.
Contact for press and media:
SurgicEye GmbH, Munich, Germany
+49 89 54 99 89 001